EPElizabeth Prentice

Elizabeth Prentice

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elizabeth Prentice has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Adrian John Brink

    Division of Medical Microbiology, Faculty of Health Sciences, University of Cape Town , Cape Town

    2 shared publications
  • Abraham J. Niehaus

    Division of Medical Microbiology, Ampath , Cape Town , South Africa

    1 shared publication
  • Amanda Julia Overmeyer

    Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town , Cape Town , South Africa

    1 shared publication
  • Andrew Whitelaw

    Division of Medical Microbiology, National Health Laboratory Service, Tygerberg Hospital , Cape Town , South Africa Division of Medical Microbiology, Faculty of Medicine and Health Sciences, Stellenbosch University , Cape Town , South Africa

    1 shared publication
  • Christine Sanders

    1 shared publication
  • Clinton Moodley

    Division of Medical Microbiology, Department of Pathology, Faculty of Health Sciences, University of Cape Town , Cape Town , South Africa

    1 shared publication

Latest Publications

  • Open Access

    Carbapenem-resistant Enterobacterales among hospitalized patients in Cape Town, South Africa: clinical and microbiological epidemiology

    by Hafsah Deepa Tootla, Elizabeth Prentice, Clinton Moodley, Gert Marais, Nyasha Nyakutira, Kessendri Reddy, Colleen Bamford, Abraham Niehaus, Andrew Whitelaw, Adrian Brink

    Carbapenem-resistant Enterobacterales (CRE) are a substantial problem in Cape Town. CRE epidemiology is largely unknown and mortality remains high. To describe and characterize the clinical and microbiological epidemiology of CRE within Cape Town hospitals to better inform therapy with regard to current and novel antibiotics, as well as improve antimicrobial stewardship (AMS), and infection prevention and control (IPC). This prospective, multicentre study performed between 1 November 2020 and 30 November 2022, across three public and three private hospitals included hospitalized participants with CRE from clinical cultures. Participant demographics, clinical information and microbiology results were collected and analysed. Ninety percent of participants were from public hospitals. The age distribution ranged from 7 days to 88 years. Notable risk factors for CRE infection included recent exposure to antibiotics, medical devices and surgery. The most prevalent species was Klebsiella pneumoniae. However, a higher proportion of Serratia marcescens compared with previous reports was identified. The detected carbapenemases were blaOXA-48-like (80%) and blaNDM (11%). With the exception of amikacin (63%), tigecycline (65%), colistin (95%) and ceftazidime/avibactam (87%), susceptibility to antibiotics was low. This study identified common risk factors for CRE infection and generated a description of carbapenemase enzymes, species distribution and antibiograms, enabling a better understanding of CRE epidemiology. This provides insights into transmission patterns and resistance determinants of CREs, beneficial to informing data-driven regional patient management, AMS and IPC strategies.


  • Open Access

    The genomic characterization of carbapenem-resistant Serratia marcescens at a tertiary hospital in South Africa

    by Amanda Julia Overmeyer, Elizabeth Prentice, Adrian Brink, Katie Lennard, Clinton Moodley

    Serratia marcescens is an opportunistic nosocomial pathogen, and recent reports have highlighted the rapid increase in multidrug resistance in this organism. There is a paucity in genomic data for carbapenem-resistant S. marcescens (CRSM). A retrospective cohort study describing laboratory-confirmed CRSM from a tertiary academic hospital in Cape Town, South Africa, for the period 2015–20, was performed. Stored CRSM and contemporary isolates were submitted for WGS using Illumina MiSeq, with the Nextera DNA Flex Library Preparation Kit. Sequence data were analysed in-house using srst2 and Tychus, and CRSM and contemporary isolates were compared. Twenty-one CRSM and four contemporary isolates were sequenced and analysed. Twenty-four different resistance genes were identified, with all isolates having at least two resistance genes, and seventeen isolates harbouring three or more genes. This correlated well with phenotypic results. The blaOXA-48-like carbapenemase was the most common carbapenemase identified, in 86% (18/21) of CRSM. A core SNP difference tree indicated that the CRSM could be grouped into three clusters. Eleven isolates had shared plasmids. Several genes and SNPs were identified in the CRSM, which may putatively augment virulence, but this requires further functional characterization. A diverse resistome was observed in CRSM, which was also reflected phenotypically, with blaOXA-48-like the most commonly carbapenemase. Though distinct clusters were observed, no clonality was noted, and a limited number of isolates shared plasmids. This study provides genomic data for emerging CRSM and highlights the importance of ongoing genomic surveillance to inform infection prevention control and antimicrobial stewardship initiatives.